Publicaciones en las que colabora con Miguel San Julián Aranguren (30)

2023

  1. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution

    eLife, Vol. 12

2022

  1. Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative HDR brachytherapy

    Radiotherapy and Oncology, Vol. 170, pp. 159-164

  2. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Clinical value of NGS genomic studies for clinical management of pediatric and young adult bone sarcomas

    Cancers, Vol. 13, Núm. 21

2020

  1. Somatic and germline analysis of a familial Rothmund–Thomson syndrome in two siblings with osteosarcoma

    npj Genomic Medicine, Vol. 5, Núm. 1

2019

  1. Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study

    Radiotherapy and Oncology, Vol. 135, pp. 91-99

2016

  1. Adjuvant radiation therapy in resected high-grade localized skeletal osteosarcomas treated with neoadjuvant chemotherapy: Long-term outcomes

    Radiotherapy and Oncology, Vol. 119, Núm. 1, pp. 30-34

  2. Consequences of Delayed Diagnosis

    Cañadell's Pediatric Bone Sarcomas (Springer), pp. 139-146

2015

  1. Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome

    Radiotherapy and Oncology, Vol. 116, Núm. 2, pp. 316-322

  2. Salvage wide resection with intraoperative electron beam therapy or HDR brachytherapy in the management of isolated local recurrences of soft tissue sarcomas of the extremities and the superficial trunk

    Brachytherapy, Vol. 14, Núm. 1, pp. 62-70

  3. Time to loading and locoregional control in perioperative high-dose-rate brachytherapy: The tumor bed effect revisited

    Brachytherapy, Vol. 14, Núm. 4, pp. 565-570

2014

  1. A proposal for the stratification of the risk of locoregional failure after surgical resection, perioperative high dose rate brachytherapy, and external beam irradiation: The University of Navarre predictive model

    Brachytherapy, Vol. 13, Núm. 4, pp. 400-404

  2. Anticipated intraoperative electron beam boost, external beam radiation therapy, and limb-sparing surgical resection for patients with pediatric soft-tissue sarcomas of the extremity: A multicentric pooled analysis of long-term outcomes

    International Journal of Radiation Oncology Biology Physics, Vol. 90, Núm. 1, pp. 172-180

  3. Prognostic value of external beam radiation therapy in patients treated with surgical resection and intraoperative electron beam radiation therapy for locally recurrent soft tissue sarcoma: A multicentric long-term outcome analysis

    International Journal of Radiation Oncology Biology Physics, Vol. 88, Núm. 1, pp. 143-150

  4. The oncolytic adenovirus Δ24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity

    Journal of Bone and Mineral Research, Vol. 29, Núm. 10, pp. 2287-2296

  5. Volume of high-dose regions and likelihood of locoregional control after perioperative high-dose-rate brachytherapy: Do hotter implants work better?

    Brachytherapy, Vol. 13, Núm. 6, pp. 591-596

2011

  1. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4

  2. Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy

    International Journal of Radiation Oncology Biology Physics, Vol. 79, Núm. 4, pp. 1158-1163

2009

  1. Methotrexate in Pediatric Osteosarcoma: Response and Toxicity in Relation to Genetic Polymorphisms and Dihydrofolate Reductase and Reduced Folate Carrier 1 Expression

    Journal of Pediatrics, Vol. 154, Núm. 5, pp. 688-693

  2. Nonreferral of possible soft tissue sarcomas in adults: A dangerous omission in policy

    Sarcoma, Vol. 2009